August 12, 2020

IN RE: Xyrem (Sodium Oxybate) Antitrust Litigation

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. December 03, 2020

    Dueling Attys Call For Xyrem MDL To Be Moved To CA Or NJ

    Lawyers for Blue Cross Blue Shield Association and Jazz Pharmaceuticals argued that lawsuits accusing Jazz of paying off rival drugmakers to delay their generic versions of Xyrem, its blockbuster narcolepsy drug, should be consolidated on either the West Coast or the East Coast in a Thursday hearing before the Judicial Panel on Multidistrict Litigation.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login